Mayne Pharma Group Ltd (MYX)

Sydney
0.330
-0.005(-1.49%)
  • Volume:
    2,124,405
  • Bid/Ask:
    0.330/0.335
  • Day's Range:
    0.325 - 0.340

MYX Overview

Prev. Close
0.335
Day's Range
0.325-0.34
Revenue
401.46M
Open
0.335
52 wk Range
0.26-0.59
EPS
-0.13
Volume
2,124,405
Market Cap
591.22M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
3,936,847
P/E Ratio
-
Beta
0.91
1-Year Change
3.08%
Shares Outstanding
1,764,840,757
Next Earnings Date
01 Dec 2021
What is your sentiment on Mayne Pharma Group Ltd?
or
Market is currently closed. Voting is open during market hours.

Mayne Pharma Group Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellBuySell
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyStrong Sell
SummaryStrong SellStrong SellStrong SellStrong BuyStrong Sell

Mayne Pharma Group Ltd Company Profile

Mayne Pharma Group Ltd Company Profile

Employees
850
Market
Australia

Mayne Pharma Group Ltd is an Australia-based specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals. The Company’s segments include Generic Products (GPD), Specialty Products (SPD), Metrics Contract Services (MCS), and Mayne Pharma International (MPI). The GPD segment is engaged in the distribution of generic pharmaceutical products in the United States. GPD segment engaged in the distribution of generic pharmaceutical products in the United States. MCS segment is providing contract pharmaceutical development and manufacturing services to third party customers principally in the United States. SPD segment is distributing specialty pharmaceutical products in the United States. MPI segment manufactures and sells branded and generic pharmaceutical products globally and provisions of contract manufacturing services to third party customers within Australia.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.